Avestar Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.85M | Sell |
7,501
-80
| -1% | -$62.4K | 0.4% | 42 |
|
|
2025
Q1 | $6.26M | Buy |
7,581
+762
| +11% | +$629K | 0.54% | 34 |
|
|
2024
Q4 | $5.26M | Buy |
6,819
+933
| +16% | +$720K | 0.45% | 44 |
|
|
2024
Q3 | $5.21M | Buy |
5,886
+722
| +14% | +$640K | 0.54% | 43 |
|
|
2024
Q2 | $4.68M | Buy |
5,164
+833
| +19% | +$754K | 0.48% | 47 |
|
|
2024
Q1 | $3.37M | Buy |
4,331
+799
| +23% | +$622K | 0.35% | 54 |
|
|
2023
Q4 | $2.06M | Buy |
3,532
+628
| +22% | +$366K | 0.23% | 57 |
|
|
2023
Q3 | $1.56M | Buy |
2,904
+538
| +23% | +$289K | 0.22% | 63 |
|
|
2023
Q2 | $1.11M | Buy |
2,366
+483
| +26% | +$227K | 0.18% | 61 |
|
|
2023
Q1 | $647K | Sell |
1,883
-31
| -2% | -$10.6K | 0.12% | 105 |
|
|
2022
Q4 | $700K | Buy |
1,914
+195
| +11% | +$71.3K | 0.13% | 97 |
|
|
2022
Q3 | $556K | Buy |
1,719
+612
| +55% | +$198K | 0.14% | 97 |
|
|
2022
Q2 | $359K | Buy |
1,107
+231
| +26% | +$74.9K | 0.09% | 149 |
|
|
2022
Q1 | $251K | Buy |
876
+128
| +17% | +$36.7K | 0.04% | 304 |
|
|
2021
Q4 | $207K | Buy |
+748
| New | +$207K | 0.03% | 335 |
|
|
2019
Q3 | – | Sell |
-437
| Closed | -$43K | – | 548 |
|
|
2019
Q2 | $43K | Sell |
437
-20
| -4% | -$1.97K | 0.03% | 314 |
|
|
2019
Q1 | $55K | Buy |
457
+1
| +0.2% | +$120 | 0.04% | 273 |
|
|
2018
Q4 | $48K | Buy |
456
+5
| +1% | +$526 | 0.03% | 265 |
|
|
2018
Q3 | $45K | Sell |
451
-81
| -15% | -$8.08K | 0.03% | 284 |
|
|
2018
Q2 | $41K | Sell |
532
-22
| -4% | -$1.7K | 0.03% | 291 |
|
|
2018
Q1 | $36K | Sell |
554
-671
| -55% | -$43.6K | 0.02% | 277 |
|
|
2017
Q4 | $100K | Buy |
+1,225
| New | +$100K | 0.07% | 156 |
|